Takip et
ELENI FRILIGKOU
ELENI FRILIGKOU
Yale School of Medine, Department of Psychiatry
Doğrulanmış e-posta adresi yok - Ana Sayfa
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Brainwide Mendelian randomization study of anxiety disorders and symptoms
MD Zanoaga, E Friligkou, J He, GA Pathak, D Koller, B Cabrera-Mendoza, ...
Biological psychiatry 95 (8), 810-817, 2024
182024
Gene discovery and biological insights into anxiety disorders from a large-scale multi-ancestry genome-wide association study
E Friligkou, S Løkhammer, B Cabrera-Mendoza, J Shen, J He, G Deiana, ...
Nature genetics 56 (10), 2036-2045, 2024
82024
Gene discovery and biological insights into anxiety disorders from a multi-ancestry genome-wide association study of> 1.2 million participants
E Friligkou, S Løkhammer, B Cabrera-Mendoza, J Shen, J He, G Deiana, ...
MedRxiv, 2024.02. 14.24302836, 2024
42024
Pleiotropy and genetically inferred causality linking multisite chronic pain to substance use disorders
D Koller, E Friligkou, B Stiltner, GA Pathak, S Løkhammer, DF Levey, ...
Molecular Psychiatry 29 (7), 2021-2030, 2024
32024
Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders
D Koller, M Mitjans, M Kouakou, E Friligkou, B Cabrera-Mendoza, ...
Psychiatry Research 333, 115758, 2024
32024
Integrating genome-wide information and wearable device data to explore the link of anxiety and antidepressants with heart rate variability
E Friligkou, D Koller, GA Pathak, EJ Miller, R Lampert, MB Stein, ...
medRxiv, 2023.08. 02.23293170, 2023
22023
Genetics of posttraumatic stress disorder and cardiovascular conditions using Life’s Essential 8, Electronic Health Records, and Heart Imaging
J Shen, W Valentim, E Friligkou, C Overstreet, K Choi, D Koller, ...
medRxiv, 2024
12024
Safety And Efficacy Of Mavacamten In Adults Wth Hypertrophic Cardiomyopathy With Obstruction. Insights From A Tertiary Center
I Konstantinidis, Z Bihag, E Friligkou, C Burke-Martindale, E Smith, ...
Journal of Cardiac Failure 31 (1), 253, 2025
2025
Integrating genome-wide information and wearable device data to explore the link of anxiety and antidepressants with pulse rate variability
E Friligkou, D Koller, GA Pathak, EJ Miller, R Lampert, MB Stein, ...
Molecular Psychiatry, 1-7, 2024
2024
Epigenetic and Genetic Profiling of Comorbidity Patterns among Substance Dependence Diagnoses
GA Pathak, RH Pietrzak, AM Lacobelle, C Overstreet, FR Wendt, JD Deak, ...
medRxiv, 2024.10. 08.24315111, 2024
2024
37. THE GENOMIC TRIAD OF INSOMNIA, ANXIETY, AND POST-TRAUMATIC STRESS DISORDER
E Tissink, A Shadrin, M Schipper, E Friligkou, R Polimanti, D Posthuma, ...
European Neuropsychopharmacology 87, 68-69, 2024
2024
47. GENE DISCOVERY AND BIOLOGICAL INSIGHTS INTO ANXIETY DISORDERS FROM A MULTI-ANCESTRY GENOME-WIDE ASSOCIATION STUDY OF> 1.2 MILLION PARTICIPANTS
E Friligkou, S Løkhammer, BC Mendoza, J Shen, J He, G Deiana, ...
European Neuropsychopharmacology 87, 74-75, 2024
2024
Sleep inertia drives the association of evening chronotype with psychiatric disorders: epidemiological and genetic evidence
AC Burns, S Zellers, DP Windred, I Daghlas, N Sinnott-Armstrong, ...
medRxiv, 2024
2024
Distinguishing vulnerability and resilience to posttraumatic stress disorder evaluating traumatic experiences, genetic risk and electronic health records
S Løkhammer, D Koller, FR Wendt, KW Choi, J He, E Friligkou, ...
Psychiatry research 337, 115950, 2024
2024
Sex differences in the associations of socioeconomic factors and cognitive performance with family history of Alzheimer’s disease
J He, B Cabrera-Mendoza, E Friligkou, AP Mecca, CH van Dyck, ...
medRxiv, 2024.06. 12.24308850, 2024
2024
T18. GENETIC CONTRIBUTION TO THE COMORBIDITY BETWEEN ATTENTION-DEFICIT HYPERACTIVITY DISORDER AND SUBSTANCE USE DISORDERS
D Koller, M Mitjans, M Kouakou, E Friligkou, BC Mendoza, J Deak, ...
European Neuropsychopharmacology 75, S171, 2023
2023
T4. FINGER ON THE PULSE: INTEGRATING GENETIC AND WEARABLE DATA TO EXPLORE THE LINK BETWEEN HEART RATE VARIABILITY, ANXIETY, AND ANTIDEPRESSANTS
E Friligkou, D Koller, G Pathak, EJ Miller, R Lampert, MB Stein, ...
European Neuropsychopharmacology 75, S164, 2023
2023
32. Defining Major Depression Sub-Phenotypes: A Multivariate Polygenic Risk Score Approach
E Friligkou, G Pathak, D Koller, R Polimanti
Biological Psychiatry 93 (9), S107, 2023
2023
A co-phenome analysis into genetic resilience and vulnerability of posttraumatic stress disorder
S Løkhammer, D Koller, FR Wendt, E Friligkou, C Overstreet, J Gelernter, ...
Neuroscience Applied 2, 103871, 2023
2023
Genetic overlap and causal relationship between multisite chronic pain and substance use disorders
D Koller, E Friligkou, G Pathak, B Stiltner, DF Levey, H Zhou, A Hatoum, ...
Neuroscience Applied 2, 102822, 2023
2023
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20